Anne Wojcicki's Nonprofit Acquires 23andMe for $305 Million
By
vidyesh
A good honest bake. Not flashy, but you'll finish the whole bagel.
Summary
Anne Wojcicki's nonprofit, TTAM Research Institute, has successfully outbid Regeneron Pharmaceuticals to acquire 23andMe for $305 million, including its assets and subsidiaries. This marks Wojcicki's return to control after stepping down as CEO when 23andMe filed for bankruptcy.
Key quotes
· 4 pulledTTAM will acquire substantially all of 23andMe's assets for $305 million, including its Personal Genome Service and Research Services business lines as well as telehealth subsidiary Lemonaid Health.
It's a big win for Wojcicki, who stepped down from her role as CEO when 23andMe filed for Chapter 11 bankruptcy protection in March.
Last month, Regeneron announced it
Anne Wojcicki, the co-founder and former CEO of 23andMe, has regained control over the embattled genetic testing company after her new nonprofit, TTAM Research Institute, outbid Regeneron Pharmaceuticals, the company announced Friday.
You might also wanna read
Dutch organizations secure €5 billion in Horizon Europe research funding
Dutch organizations participating in the EU's Horizon Europe program have collectively secured €5 billion in European funding for research a
ioplus.nl·4h ago
Negative electricity pricing: When renewable energy is so abundant utilities pay people to use power
Negative electricity pricing is an emerging phenomenon in decarbonizing power grids where renewable energy is so abundant that utilities som
anthropocenemagazine.org·1d agoNegative electricity pricing: When renewable energy is so abundant utilities pay people to use power
Negative electricity pricing is an emerging phenomenon in decarbonizing power grids where renewable energy is so abundant that utilities som
anthropocenemagazine.org·1d ago
Strait of Hormuz sulfur price spike signals future fertilizer cost challenges as fossil fuel byproduct supply declines
The article discusses how the Strait of Hormuz sulfur price spike reveals a critical vulnerability in global fertilizer supply chains. Sulfu
cleantechnica.com·2d ago
Protuoso Biosciences raises $9.5M for AI-designed multifunctional biologic drugs
Protuoso Biosciences, a California-based startup, has raised $9.5 million to advance its AI-designed multifunctional biologics platform. The
longevity.technology·2d ago
Research integrity activists find evidence of image manipulation in Thermo Fisher antibody catalog
Research integrity activists have uncovered evidence of widespread image manipulation in Thermo Fisher Scientific's catalog of antibody reag
cenm.ag·2d ago